News and Trends 30 May 2023
Molecular Partners presenting positive solid tumor data
Molecular Partners AG will present additional positive data from the ongoing phase 1 study of MP0317, a CD40 agonist designed…
Molecular Partners
- Latest Posts
Interview 16 May 2019
Taking a Drug to Market “Is a Marathon, Not a Sprint”
Based in Zurich, Molecular Partners is developing a new class of drugs that can address the complexity of cancer. At…
Best in Biotech 15 Mar 2017
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look…
News and Trends 11 Jul 2016
How to build a Successful Biotech company in Europe with Joern Aldag
Joern Aldag is one of the impressive Biotech leaders in Europe. Hearing him at our Refresh conference made me think…
ADVERTISEMENT
News and Trends 7 Jun 2016
Zurich is not all about Money – here are 9 Biotechs proving it!
The biggest city in Switzerland, Zurich, is one of Europe's top financial centers and home to the SIX Swiss Exchange…
News and Trends 4 Apr 2016
Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference was about partnering, trends and…
News and Trends 27 Jul 2015
Roche exits €940M discovery alliance with Molecular Partners
Roche left the collaboration with Molecular Partners, walking away from a potential cancer treatment using the DARPin technology. The collaboration,…
News and Trends 6 Feb 2015
2014, the Biggest Year Ever for European Biotech IPOs
There is no need to say it: biotechnology is the latest trend. A worldwide bio-boom has shaken stock markets throughout…
